Cortexin

Cortexin is a neuropeptide complex extracted from cattle brain cortex containing low-molecular-weight peptides and amino acids with neurotrophic and neuroprotective properties. Used extensively in Russia and Eastern European countries, Cortexin is approved for treatment of various neurological conditions including stroke, traumatic brain injury, encephalopathy, and cognitive disorders. Research demonstrates the preparation supports neuronal metabolism, reduces neuroinflammation, modulates neurotransmitter balance, and promotes functional recovery after brain injury. Clinical studies show improvements in cognitive function, memory, attention, and neurological recovery in various patient populations. The peptide complex is administered intramuscularly and is proposed to cross the blood-brain barrier to exert central effects. Cortexin contains multiple bioactive components that may act synergistically on neuronal tissue. While widely used clinically in some countries, the preparation lacks large-scale randomized controlled trials meeting Western regulatory standards. Research continues into its mechanisms of action and potential applications for neurodegenerative diseases and age-related cognitive decline.

Small sample sizes; publications are mostly Russian-language with limited independent replication; Cortexin is a complex, incompletely characterized peptide mixture with manufacturing standardization questions; no robust Western clinical trials; pharmacokinetic documentation is poor.

Administered intramuscularly as a registered Russian drug. It is a complex of low-molecular-weight polypeptides isolated from mammalian (bovine/pig) cerebral cortex. Pharmacokinetic data (half-life, bioavailability) are not well documented in accessible literature.